Use of complementary and alternative medicine for inflammatory bowel disease is associated with worse adherence to conventional therapy: The COMPLIANT study

Geoffrey C. Nguyen, Ken Croitoru, Mark S. Silverberg, A. Hillary Steinhart, Adam V. Weizman

Research output: Contribution to journalArticle

Abstract

Background: Complementary and alternative medicine (CAM) use is highly prevalent among inflammatory bowel disease (IBD patients). We assessed whether its use, both for IBD and for general health, influenced adherence to conventional medications. Methods: We enrolled 392 IBD subjects in a prospective cohort study and categorized them as CAM nonusers (38%) and those who used CAM for general health (CAM-GEN, 41%) and for IBD (CAM-IBD, 21%). Their self-reported adherence was measured using the 4-item Morisky Adherence Scale during a median follow-up period of 6.8 months. Results: CAM-IBD users were less likely to be adherent to medical therapy than CAM nonusers and CAM-GEN users (70% vs. 84% and 81%, respectively, P <0.05). Nearly all subjects who were nonadherent reported that it was unintentional (97%), and this did not vary use of CAM. After adjusting for confounders, the adjusted odds ratio for adherence among CAM-IBD relative to CAM nonuser was 0.47 (95% CI, 0.22-0.96). CAM-GEN demonstrated similar adherence to CAM nonusers (adjusted odds ratio, 0.85; 95% CI, 0.44-1.66). CAM-IBD was also less likely than CAM nonusers and CAM-GEN to have improvement in their adherence scores during follow-up (14% vs. 33% and 34%, respectively, P <0.01). The adjusted odds ratio for improved adherence in CAM-IBD compared with CAM nonusers and CAM-GEN were 0.32 (95% CI, 0.15-0.69) and 0.34 (95% CI, 0.16-0.72), respectively. Conclusions: CAM-IBD, but not CAM-GEN, was associated with lower adherence to IBD medical therapy. A third of CAM nonusers and CAM-GEN improved adherence during the observation period, suggesting a Hawthorne effect.

Original languageEnglish (US)
Pages (from-to)1412-1417
Number of pages6
JournalInflammatory Bowel Diseases
Volume22
Issue number6
DOIs
StatePublished - Jun 1 2016
Externally publishedYes

Fingerprint

Complementary Therapies
Inflammatory Bowel Diseases
Therapeutics

Keywords

  • complementary and alternative medicine
  • Crohn's disease
  • inflammatory bowel disease
  • medication adherence
  • ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Use of complementary and alternative medicine for inflammatory bowel disease is associated with worse adherence to conventional therapy : The COMPLIANT study. / Nguyen, Geoffrey C.; Croitoru, Ken; Silverberg, Mark S.; Steinhart, A. Hillary; Weizman, Adam V.

In: Inflammatory Bowel Diseases, Vol. 22, No. 6, 01.06.2016, p. 1412-1417.

Research output: Contribution to journalArticle

Nguyen, Geoffrey C. ; Croitoru, Ken ; Silverberg, Mark S. ; Steinhart, A. Hillary ; Weizman, Adam V. / Use of complementary and alternative medicine for inflammatory bowel disease is associated with worse adherence to conventional therapy : The COMPLIANT study. In: Inflammatory Bowel Diseases. 2016 ; Vol. 22, No. 6. pp. 1412-1417.
@article{e29a3635c6a84017b0696487c8a766f1,
title = "Use of complementary and alternative medicine for inflammatory bowel disease is associated with worse adherence to conventional therapy: The COMPLIANT study",
abstract = "Background: Complementary and alternative medicine (CAM) use is highly prevalent among inflammatory bowel disease (IBD patients). We assessed whether its use, both for IBD and for general health, influenced adherence to conventional medications. Methods: We enrolled 392 IBD subjects in a prospective cohort study and categorized them as CAM nonusers (38{\%}) and those who used CAM for general health (CAM-GEN, 41{\%}) and for IBD (CAM-IBD, 21{\%}). Their self-reported adherence was measured using the 4-item Morisky Adherence Scale during a median follow-up period of 6.8 months. Results: CAM-IBD users were less likely to be adherent to medical therapy than CAM nonusers and CAM-GEN users (70{\%} vs. 84{\%} and 81{\%}, respectively, P <0.05). Nearly all subjects who were nonadherent reported that it was unintentional (97{\%}), and this did not vary use of CAM. After adjusting for confounders, the adjusted odds ratio for adherence among CAM-IBD relative to CAM nonuser was 0.47 (95{\%} CI, 0.22-0.96). CAM-GEN demonstrated similar adherence to CAM nonusers (adjusted odds ratio, 0.85; 95{\%} CI, 0.44-1.66). CAM-IBD was also less likely than CAM nonusers and CAM-GEN to have improvement in their adherence scores during follow-up (14{\%} vs. 33{\%} and 34{\%}, respectively, P <0.01). The adjusted odds ratio for improved adherence in CAM-IBD compared with CAM nonusers and CAM-GEN were 0.32 (95{\%} CI, 0.15-0.69) and 0.34 (95{\%} CI, 0.16-0.72), respectively. Conclusions: CAM-IBD, but not CAM-GEN, was associated with lower adherence to IBD medical therapy. A third of CAM nonusers and CAM-GEN improved adherence during the observation period, suggesting a Hawthorne effect.",
keywords = "complementary and alternative medicine, Crohn's disease, inflammatory bowel disease, medication adherence, ulcerative colitis",
author = "Nguyen, {Geoffrey C.} and Ken Croitoru and Silverberg, {Mark S.} and Steinhart, {A. Hillary} and Weizman, {Adam V.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1097/MIB.0000000000000773",
language = "English (US)",
volume = "22",
pages = "1412--1417",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Use of complementary and alternative medicine for inflammatory bowel disease is associated with worse adherence to conventional therapy

T2 - The COMPLIANT study

AU - Nguyen, Geoffrey C.

AU - Croitoru, Ken

AU - Silverberg, Mark S.

AU - Steinhart, A. Hillary

AU - Weizman, Adam V.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background: Complementary and alternative medicine (CAM) use is highly prevalent among inflammatory bowel disease (IBD patients). We assessed whether its use, both for IBD and for general health, influenced adherence to conventional medications. Methods: We enrolled 392 IBD subjects in a prospective cohort study and categorized them as CAM nonusers (38%) and those who used CAM for general health (CAM-GEN, 41%) and for IBD (CAM-IBD, 21%). Their self-reported adherence was measured using the 4-item Morisky Adherence Scale during a median follow-up period of 6.8 months. Results: CAM-IBD users were less likely to be adherent to medical therapy than CAM nonusers and CAM-GEN users (70% vs. 84% and 81%, respectively, P <0.05). Nearly all subjects who were nonadherent reported that it was unintentional (97%), and this did not vary use of CAM. After adjusting for confounders, the adjusted odds ratio for adherence among CAM-IBD relative to CAM nonuser was 0.47 (95% CI, 0.22-0.96). CAM-GEN demonstrated similar adherence to CAM nonusers (adjusted odds ratio, 0.85; 95% CI, 0.44-1.66). CAM-IBD was also less likely than CAM nonusers and CAM-GEN to have improvement in their adherence scores during follow-up (14% vs. 33% and 34%, respectively, P <0.01). The adjusted odds ratio for improved adherence in CAM-IBD compared with CAM nonusers and CAM-GEN were 0.32 (95% CI, 0.15-0.69) and 0.34 (95% CI, 0.16-0.72), respectively. Conclusions: CAM-IBD, but not CAM-GEN, was associated with lower adherence to IBD medical therapy. A third of CAM nonusers and CAM-GEN improved adherence during the observation period, suggesting a Hawthorne effect.

AB - Background: Complementary and alternative medicine (CAM) use is highly prevalent among inflammatory bowel disease (IBD patients). We assessed whether its use, both for IBD and for general health, influenced adherence to conventional medications. Methods: We enrolled 392 IBD subjects in a prospective cohort study and categorized them as CAM nonusers (38%) and those who used CAM for general health (CAM-GEN, 41%) and for IBD (CAM-IBD, 21%). Their self-reported adherence was measured using the 4-item Morisky Adherence Scale during a median follow-up period of 6.8 months. Results: CAM-IBD users were less likely to be adherent to medical therapy than CAM nonusers and CAM-GEN users (70% vs. 84% and 81%, respectively, P <0.05). Nearly all subjects who were nonadherent reported that it was unintentional (97%), and this did not vary use of CAM. After adjusting for confounders, the adjusted odds ratio for adherence among CAM-IBD relative to CAM nonuser was 0.47 (95% CI, 0.22-0.96). CAM-GEN demonstrated similar adherence to CAM nonusers (adjusted odds ratio, 0.85; 95% CI, 0.44-1.66). CAM-IBD was also less likely than CAM nonusers and CAM-GEN to have improvement in their adherence scores during follow-up (14% vs. 33% and 34%, respectively, P <0.01). The adjusted odds ratio for improved adherence in CAM-IBD compared with CAM nonusers and CAM-GEN were 0.32 (95% CI, 0.15-0.69) and 0.34 (95% CI, 0.16-0.72), respectively. Conclusions: CAM-IBD, but not CAM-GEN, was associated with lower adherence to IBD medical therapy. A third of CAM nonusers and CAM-GEN improved adherence during the observation period, suggesting a Hawthorne effect.

KW - complementary and alternative medicine

KW - Crohn's disease

KW - inflammatory bowel disease

KW - medication adherence

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84970956396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970956396&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000000773

DO - 10.1097/MIB.0000000000000773

M3 - Article

C2 - 27120570

AN - SCOPUS:84970956396

VL - 22

SP - 1412

EP - 1417

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 6

ER -